We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Phase 2a Study of IW-6463 in Adults Diagnosed With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04475549
Recruitment Status : Terminated (Study terminated due to enrollment challenges.)
First Posted : July 17, 2020
Last Update Posted : January 25, 2023
Information provided by (Responsible Party):
Cyclerion Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 23, 2022
Actual Study Completion Date : January 23, 2022
Certification/Extension First Submitted : January 20, 2023